LE
LEO Pharma
Ballerup DKFounded 19086,000 employees
Private CappharmaPrivateDermatology
Platform: Derm Specialty
Market Cap
N/A
All Drugs
4
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimanaritide | LEO-8908 | Phase 3 | 1 | CD123 | SLERSV | ||
| Sotozanubrutinib | LEO-5634 | Phase 2/3 | 1 | APOC3 | Atopic DermPAH | ||
| Kematenlimab | LEO-5067 | Phase 2/3 | 1 | VEGF | SchizophreniaWet AMD | ||
| LEO-5676 | LEO-5676 | Phase 2/3 | 1 | PCSK9 | MS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)